Cargando…

Achieving meaningful participation of people who use drugs and their peer organizations in a strategic research partnership

BACKGROUND: Peer-led programs with people who use drugs (PWUD) have been a key characteristic of the harm reduction in many countries, including their involvement in research. However, peer involvement in research is often limited to recruitment, consultation, and reporting back, rather than a genui...

Descripción completa

Detalles Bibliográficos
Autores principales: Brown, Graham, Crawford, Sione, Perry, Gari-Emma, Byrne, Jude, Dunne, James, Reeders, Daniel, Corry, Angela, Dicka, Jane, Morgan, Hunter, Jones, Sam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6558880/
https://www.ncbi.nlm.nih.gov/pubmed/31182099
http://dx.doi.org/10.1186/s12954-019-0306-6
_version_ 1783425723094007808
author Brown, Graham
Crawford, Sione
Perry, Gari-Emma
Byrne, Jude
Dunne, James
Reeders, Daniel
Corry, Angela
Dicka, Jane
Morgan, Hunter
Jones, Sam
author_facet Brown, Graham
Crawford, Sione
Perry, Gari-Emma
Byrne, Jude
Dunne, James
Reeders, Daniel
Corry, Angela
Dicka, Jane
Morgan, Hunter
Jones, Sam
author_sort Brown, Graham
collection PubMed
description BACKGROUND: Peer-led programs with people who use drugs (PWUD) have been a key characteristic of the harm reduction in many countries, including their involvement in research. However, peer involvement in research is often limited to recruitment, consultation, and reporting back, rather than a genuine collaboration in the priority setting, design, and conduct of research. PWUD peer organizations face ongoing challenges to demonstrate the depth of their knowledge of current and emerging issues within drug-using networks and the value of their peer insights for effective research and policy. The identification of benefits, barriers, and enablers for meaningful participation of PWUD in research has often been limited to methodological rather than system level factors. METHODS: This paper draws on the experiences and findings of the What Works and Why (W3) Project, a 5-year collaborative study with peer organizations. The study drew on systems thinking methods to develop a framework to demonstrate the role of peer organizations within their community and policy systems. The study required peer staff and researchers to undertake the simultaneous role of drivers, participants, and analysts in the research. To identify the learnings in relation to meaningful participation of PWUD peer organizations in research, we drew together the insights and experiences of peer staff and researchers across the 5 years of the study RESULTS: The W3 Project provided insights into the nuances of community-engaged research practice and the ongoing benefits, barriers, and enablers to the meaningful participation of PWUD and their peer organizations. These included system-level barriers and enablers beyond individual research projects or methodology. The capacity of research and peer organizations to maintain meaningful peer participation in research can be restricted or enhanced by the systems in which they are embedded. CONCLUSIONS: Recognizing peer organizations as active participants and drivers within community and policy systems can help clarify their unique and critical role in research. Achieving meaningful collaboration with PWUD peer organizations requires looking beyond good practice methods to the system-level factors with attention to the system-level benefits, barriers, and enablers.
format Online
Article
Text
id pubmed-6558880
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-65588802019-06-13 Achieving meaningful participation of people who use drugs and their peer organizations in a strategic research partnership Brown, Graham Crawford, Sione Perry, Gari-Emma Byrne, Jude Dunne, James Reeders, Daniel Corry, Angela Dicka, Jane Morgan, Hunter Jones, Sam Harm Reduct J Methodology BACKGROUND: Peer-led programs with people who use drugs (PWUD) have been a key characteristic of the harm reduction in many countries, including their involvement in research. However, peer involvement in research is often limited to recruitment, consultation, and reporting back, rather than a genuine collaboration in the priority setting, design, and conduct of research. PWUD peer organizations face ongoing challenges to demonstrate the depth of their knowledge of current and emerging issues within drug-using networks and the value of their peer insights for effective research and policy. The identification of benefits, barriers, and enablers for meaningful participation of PWUD in research has often been limited to methodological rather than system level factors. METHODS: This paper draws on the experiences and findings of the What Works and Why (W3) Project, a 5-year collaborative study with peer organizations. The study drew on systems thinking methods to develop a framework to demonstrate the role of peer organizations within their community and policy systems. The study required peer staff and researchers to undertake the simultaneous role of drivers, participants, and analysts in the research. To identify the learnings in relation to meaningful participation of PWUD peer organizations in research, we drew together the insights and experiences of peer staff and researchers across the 5 years of the study RESULTS: The W3 Project provided insights into the nuances of community-engaged research practice and the ongoing benefits, barriers, and enablers to the meaningful participation of PWUD and their peer organizations. These included system-level barriers and enablers beyond individual research projects or methodology. The capacity of research and peer organizations to maintain meaningful peer participation in research can be restricted or enhanced by the systems in which they are embedded. CONCLUSIONS: Recognizing peer organizations as active participants and drivers within community and policy systems can help clarify their unique and critical role in research. Achieving meaningful collaboration with PWUD peer organizations requires looking beyond good practice methods to the system-level factors with attention to the system-level benefits, barriers, and enablers. BioMed Central 2019-06-10 /pmc/articles/PMC6558880/ /pubmed/31182099 http://dx.doi.org/10.1186/s12954-019-0306-6 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Methodology
Brown, Graham
Crawford, Sione
Perry, Gari-Emma
Byrne, Jude
Dunne, James
Reeders, Daniel
Corry, Angela
Dicka, Jane
Morgan, Hunter
Jones, Sam
Achieving meaningful participation of people who use drugs and their peer organizations in a strategic research partnership
title Achieving meaningful participation of people who use drugs and their peer organizations in a strategic research partnership
title_full Achieving meaningful participation of people who use drugs and their peer organizations in a strategic research partnership
title_fullStr Achieving meaningful participation of people who use drugs and their peer organizations in a strategic research partnership
title_full_unstemmed Achieving meaningful participation of people who use drugs and their peer organizations in a strategic research partnership
title_short Achieving meaningful participation of people who use drugs and their peer organizations in a strategic research partnership
title_sort achieving meaningful participation of people who use drugs and their peer organizations in a strategic research partnership
topic Methodology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6558880/
https://www.ncbi.nlm.nih.gov/pubmed/31182099
http://dx.doi.org/10.1186/s12954-019-0306-6
work_keys_str_mv AT browngraham achievingmeaningfulparticipationofpeoplewhousedrugsandtheirpeerorganizationsinastrategicresearchpartnership
AT crawfordsione achievingmeaningfulparticipationofpeoplewhousedrugsandtheirpeerorganizationsinastrategicresearchpartnership
AT perrygariemma achievingmeaningfulparticipationofpeoplewhousedrugsandtheirpeerorganizationsinastrategicresearchpartnership
AT byrnejude achievingmeaningfulparticipationofpeoplewhousedrugsandtheirpeerorganizationsinastrategicresearchpartnership
AT dunnejames achievingmeaningfulparticipationofpeoplewhousedrugsandtheirpeerorganizationsinastrategicresearchpartnership
AT reedersdaniel achievingmeaningfulparticipationofpeoplewhousedrugsandtheirpeerorganizationsinastrategicresearchpartnership
AT corryangela achievingmeaningfulparticipationofpeoplewhousedrugsandtheirpeerorganizationsinastrategicresearchpartnership
AT dickajane achievingmeaningfulparticipationofpeoplewhousedrugsandtheirpeerorganizationsinastrategicresearchpartnership
AT morganhunter achievingmeaningfulparticipationofpeoplewhousedrugsandtheirpeerorganizationsinastrategicresearchpartnership
AT jonessam achievingmeaningfulparticipationofpeoplewhousedrugsandtheirpeerorganizationsinastrategicresearchpartnership